David Stepek

Statistics

Publications

Citations

106

H-Index

Active since

2021

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Medical University of Vienna

David Stepek is an author at Icahn School of Medicine at Mount Sinai specializing in inflammatory bowel disease therapy, inflammatory colitis, and immunology.

Publications per year

2021–2025

Publications

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

OP41 Duvakitug (TEV-48574), an anti-TL1a monoclonal antibody, demonstrates efficacy and favourable safety as an induction treatment in adults with moderately to severely active ulcerative colitis: Results from a phase 2b, randomised, double-blind, placebo-controlled, dose-ranging, basket trial (RELIEVE UCCD)

Walter Reinisch, David Stepek, Radosław Kempiński et al. · Journal of Crohn s and Colitis · 2025 · 13 citations · Full text

Life Sciences, Immunology, Pharmacology +17

1–2 of 2